Characteristics of CAM users and non-CAM users (N = 546).
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://figshare.com/articles/dataset/_Characteristics_of_CAM_users_and_non_CAM_users_N_546_/1571812
下载链接
链接失效反馈官方服务：
资源简介：
a Other ethnic groups were excluded from the analysis
b FEC (5-fluorouracil/5-FU, epirubicin and cyclophosphamide), FAC (5-FU, doxorubicin and cyclophosphamide), CMF (cyclophosphamide, methotrexate and 5FU), AC (doxorubicin and cyclophosphamide)
c Fisher’s exact test
d An adaptation of the 16-item Side Effect Burden Scale [35] was used to measure patients’ symptom burden. K-means clustering was used to divide patients into 2 clusters of high and low total symptom burden.
* Significance level at p < 0.05
**Significance level at p < 0.01
***Significance level at p < 0.001
Characteristics of CAM users and non-CAM users (N = 546).
创建时间：
2015-10-09
